Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Trump-appointed judge blocks approval of widely used abortion drug in decision that threatens access nationwide

A federal judge in Texas will halt the FDA’s approval of mifepristone in seven days unless an appeals court intervenes. But the decision was quickly contradicted by a separate ruling, setting up more legal challenges

The Independent UK

Dual court rulings throw confusion into abortion drug debate - Roll Call

Two federal judges issued dueling opinions Friday over the FDA's approval of an abortion drug more than 20 years ago.

Roll Call

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Unravel the true secret to 10 year natural facial youth

BEYOND BEAUTY CHANNEL BY DR. NIDA

Bangkok Post

California lawmaker wants Peeps to change its ingredients

A bill in the California Legislature would ban five chemicals found in some of the most popular candy in the U.S. The bill by Assemblymember Jesse Gabriel would ban chemicals found in candy like Skittles, Starbursts and Peeps

The Independent UK

The FDA's rule change requiring providers to inform women about breast density could lead to a flurry of questions

The U.S. Food and Drug Administration finalized a regulation in early March 2023 that updates mammography reporting requirements. The new regulation goes into effect on Sept. 10, 2024, and will require that all women receive information about breast density following a mammogram. It will also require they be told in…

The Conversation

The Abortion Debate Is Messy. Two Lawsuits Against the FDA May Make It Worse.

Litigation over abortion drugs turns disagreements about individual rights into a bureaucratic tussle.

Reason

Read news from The Economist, FT, and more,
with one subscription

Unsafe cadmium level detected in seaweed product

The Food and Drug Administration (FDA) has warned people not to consume a certain lot of roasted nori seaweed products due to potential contamination of cadmium.

Bangkok Post

FDA pulls the only approved drug for preventing premature birth off the market

The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.

WEKU

Makers of Peeps urged to remove cancer-causing dye from marshmallow candies

The candy manufacturer defended using the food dye on the basis that it is ‘currently an approved colourant for use in candy by the FDA’

The Independent UK

3 Low P/E Stocks Gearing Up to Rebound This Year

Recent banking turmoil and rising interest rates have weighed heavily on investors’ sentiment lately. However, weak economic data signaling slowing growth could result in relatively easy monetary policies in the second half of 2023. Given the macroeconomic backdrop, investors could consider adding fundamentally sound low P/E stocks Pfizer (PFE), Chevron…

StockNews.com

FDA forces unproven premature birth drug Makena off market

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

The Independent UK

Are We Near The End Of Animal Testing?

Cutting-edge new tech could halt animal testing in drug development — but some old-fashioned methods may stick around.

Inverse

Peter Welch on being the Senate’s (old) new guy, dairy, and how Dems like him win rural voters

WASHINGTON — At the tender age of 75, Peter Welch is starting from scratch, in a way. Welch became one of the oldest freshmen to ever roam the Senate’s hallways after winning the seat vacated by one of the longest-serving senators ever, Patrick Leahy.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Legislative themes emerge on upcoming pandemic reauthorization

WASHINGTON — The broad outlines of an upcoming debate over a pandemic preparedness reauthorization bill are beginning to emerge as regulators, policymakers and industry groups take stock of lessons learned from COVID-19.

Roll Call

Legislative themes emerge on upcoming pandemic reauthorization - Roll Call

A reauthorization of the pandemic preparedness law will give Congress a chance to revisit its handling of COVID-19.

Roll Call

Peter Welch on being the Senate's (old) new guy, dairy, and how Dems like him win rural voters - Roll Call

At the age of 75, Peter Welch became one of the oldest freshmen to ever roam the Senate’s hallways after winning a vacated seat.

Fortune

Birth control fail: Why American women can’t have better contraceptives in 2023

The rocky history of Evofem and Phexxi illuminates how big insurers and drugmakers are stifling innovation in women’s health.

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

Doctors are drowning in paperwork. Some companies claim AI can help

New startups believe chatbot technology could help reduce the burden on physicians. But some academics warn bias and errors could hurt patients.

Tribune News Service

FDA approval of Narcan as over-the-counter drug will boost accessibility, save lives, health officials say

BALTIMORE — As soon as this summer, people will be able to purchase the opioid overdose reversal medication Narcan as easily as they can buy Tylenol and Benadryl, after the U.S. Food and Drug Administration approved it last week to be sold over the counter.

Bangkok Post

FDA warns public of toxic hair dye

The Food and Drug Administration (FDA) on Tuesday warned consumers that three South Korean hair-dyeing products contain cancer-causing chemicals.

The Independent UK

Washington stocks up on abortion pills ahead of court ruling

Washington state officials have purchased a three-year supply of a leading abortion medication in anticipation of a court ruling that could limit its availability

Tribune News Service

Washington state stockpiles abortion pills ahead of federal court ruling

OLYMPIA, Wash. — Washington has stockpiled thousands of doses of an abortion pill in anticipation of a federal court ruling in Texas that could limit its availability, Gov. Jay Inslee said Tuesday.

WEKU

Washington state stockpiles thousands of abortion pills

Democratic state officials say they're ready to dispense thousands of mifepristone doses if access to the pill becomes difficult as a result of a pending federal lawsuit.

The Independent UK

Eyedrops maker couldn't ensure factory was sterile, FDA says

The Food and Drug Administration says it found a host of problems at an Indian manufacturing plant recently linked to contaminated eyedrops

1 … 161 162 163 164

People

Cathy McMorris Rodgers

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.